Lyon Registry of Stroke Treated by Thrombolysis or Thrombectomy

Ischemic Stroke Clinical Trial

— RELATE  

Official title:

Lyon Registry of Stroke Treated by Thrombolysis or Thrombectomy

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04620642
• Other study ID #: 69HCL20_0924
• Status: Recruiting
• Start date: August 1, 2020
• Est. completion date: March 2031

Study information

• Verified date: November 2020
• Source: Hospices Civils de Lyon
• Contact: Tae Hee CHO, MD
• Phone: 0033 4 72 35 78 07
• Email: tae-hee.cho[@]chu-lyon.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This observational study as an objective of characterizing the population of patients treated within the neurovascular unit of the Pierre Wertheimer hospital (Hospices Civils de Lyon) in order to determine their phenotype (age, sex, risk factors, etc.) and its evolution over time. It also aims to assess the management of ischemic stroke (IS) in the neurovascular unit of Pierre Wertheimer Hospital. We will assess in particular the pre-hospital and hospital care times, the type of medical care (thrombolysis and / or thrombectomy) as well as the efficiency of this care (effective recanalization, outcome of patient, etc.).

Description:

All patient who has had an IS with an indication of thrombolysis and / or thrombectomy, hospitalized in the neurovascular unit of Pierre Wertheimer Hospital (HCL) since January 2013 and until December 2030 will be contacted for this study

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 4500
• Est. completion date: March 2031
• Est. primary completion date: March 2031
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• - Patients over 18 years old,

• Hospitalization in the neurovascular unit of the Pierre Wertheimer Neurological Hospital (Hospices Civils de Lyon),

• Ischemic stroke treated by thrombolysis and / or mechanical thrombectomy.

Exclusion Criteria:

• - Opposition to this research.

Related Conditions & MeSH terms

• Ischemic Stroke
• Stroke

Intervention

Biological:
• Registry
No specific intervention. Data of the usual care will be collected as the medical history, the demographic data, the biological analyses, imaging report, etc.

Locations

Country	Name	City	State
France	Hôpital Pierre Wertheimer, GHE, HCL	Lyon

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Phenotype of the population	Characterization the population of patients with stroke treated by thrombolysis and / or thrombectomy in the neurovascular unit of the Pierre Wertheimer Hospital, Hospices Civils de Lyon : age, sex, risk factors, becoming, etc.	3 months